Panagora Asset Management
CTSO icon

Panagora Asset Management’s Cytosorbents Corp CTSO Stock Holding History

Panagora Asset Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,310
Closed -$609K – 2429
2015
Q1 		$609K Buy
+2,310
New +$475K ﹤0.01% 1239

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American International Group
American International Group New York $4.18M AUM 73.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Glenmede Trust
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Commerzbank Aktiengesellschaft
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

Panagora Asset Management's CTSO Position: Q2 2015 in Review

Panagora Asset Management sold out of Cytosorbents Corp (CTSO) in Q2 2015, closing a stake of 2,310 shares — an estimated $609K sold.

Panagora Asset Management first reported a position in CTSO in Q1 2015 and held it in 1 quarter. The position peaked at $609K in Q1 2015. 31 funds tracked by Wall St. Rank hold CTSO as of Q2 2015.

  • Panagora Asset Management reported no remaining Cytosorbents Corp position as of Q2 2015 after selling out during the quarter.
  • Panagora Asset Management sold 2,310 Cytosorbents Corp shares in Q2 2015, an estimated $609K.
  • Panagora Asset Management first reported a position in Cytosorbents Corp in Q1 2015 and held it in 1 quarter.
  • Panagora Asset Management's Cytosorbents Corp position peaked at $609K in Q1 2015.
  • 31 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2015.

Based on Panagora Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.